Did You Know...
...that the Eveready Battery began as an invention called the "electric flowerpot," which was a tube with a battery and light bulb inside? The idea was to fasten this gizmo to the side of a flowerpot so it would illuminate the flowers from the bottom. The idea died on the vine and the businessman who licensed the flower pot, Conrad Huber, was left with a pile of useless tubes -- until he found a way to market them as batteries to light the world!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7256184 | Treatment of aging disorders in humans A method for the treatment and prophylaxis of conditions of aging in humans, such conditions of aging associated with a decreased presence of one or more cell-specific carbonic anhydrase enzymes. Such conditions include chronic neurodegenerative conditions including... | 08/14/2007 |
| 7001617 | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals The invention relates to a method to induce apoptosis and to inhibit matrix metalloproteinases in a disease condition in a human or animal by contacting hyperplastic tissue, tumor tissue, or a cancerous lesion with one or more antimicrobial metals, preferably formed... | 02/21/2006 |
| 6919306 | Method of skin care The present invention provides a method for skin care by orally administering a skin care agent comprising an ingestible carrier and natural-type N-acetylglucosamine obtainable by hydrolysis of chitin with an acid, an enzyme, or an acid and an enzyme, wherein the na... | 07/19/2005 |
| 6887898 | Pharmaceutical compositions useful in prevention and treatment of beta-Amyloid protein-induced disease The invention provides methods for treating beta-Amyloid protein-induced disease, pharmaceutical compositions and compounds useful for the same, and the use of these compounds for the manufacture of a medicament for treating the same. More particularly, the inventio... | 05/03/2005 |
| 6821997 | Therapeutic and prophylactic treatment of aging and disorders of aging in humans A method for the treatment and prophylaxis of conditions of aging in humans, such conditions of aging associated with a decreased presence of cell-specific carbonic anhydrase enzymes in the brain, such as conditions associated with chronic neurodegenerative conditio... | 11/23/2004 |
| 6660757 | Use of riluzole in the treating acoustic traumas The invention concerns the use of riluzole or one of its pharmaceutically acceptable salts for preventing and/or treating acoustic traumas and, in particular, different types of deafness and tinnitus.... | 12/09/2003 |
| 6608064 | Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas The present invention is directed to the use of certain pyrido[1,2-a]-pyrazine derivatives, also described as bis-azabicyclic compounds and defined by the formula (I) herein, in the treatment of Parkinson's disease, attention deficit hyperactivity disorde... | 08/19/2003 |
| 6596745 | Method for treating fibrotic diseases with azolium chroman compounds Provided is a method of treating or ameliorating hypertension in an animal comprising administering an effective amount of a compound of formula I: ##STR1##... | 07/22/2003 |
| 6596709 | 6-sulphanoyl-3-quinolylphosphonic acid compounds The invention relates to a compound of formula (I): ##STR1## wherein: X represents chlorine or fluorine or CF3, R represents hydrogen or a group ##STR2## and methods for using the same.... | 07/22/2003 |
| 6589944 | Breakers of advanced glycation endproducts Advanced glycation endproducts (AGEs) have been implicated in the pathogenesis of a variety of debilitating diseases such as diabetes, atherosclerosis, Alzheimer's and rheumatoid arthritis, as well as in the normal aging process. Five compounds are here r... | 07/08/2003 |
| 6552087 | Therapeutic agent comprising (+)-sibutramine The use of (+)-sibutramine in the treatment of depression, obesity, Parkinson's disease, cerebral function disorders and diabetes is described.... | 04/22/2003 |
| 6518250 | Agent for preventing and curing hindrance of ischemic reperfusion An agent for preventing and curing the hindrance of ischemic reperfusiton is disclosed which has as an active component thereof a chromanol glycoside represented by the following general formula: ##STR1## [wherein R1, R2, R3 | 02/11/2003 |
| 6506746 | Method for treating cognitive dysfunction The invention provides a method of treating a cognitive dysfunction comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b][1,5]benzodiazepine.... | 01/14/2003 |
| 6391917 | Dialkyl ureas as calcitonin mimetics Dialkyl urea compounds are described which act as calcitonin mimetics. These compounds are useful in the treatment of diseases which are associated with bone resorption. The calcitonin mimetics of the present invention are also useful in assays for the de... | 05/21/2002 |
| 6380267 | Composition and method for decreasing neurologic symptomatology A method of decreasing the signs or symptomatology in a patient with a neurologic condition or disease, or in a patient due to effects of exposure to an exogenous substance, such as a pharmaceutical agent, comprising selecting a patient having at least on... | 04/30/2002 |
| 6348213 | Method for reversing age-related changes in heart muscle cells A method of-treating a relatively aged animal to reverse age-related changes in the lipid composition of organ and tissue cells, such as heart muscle cells, and the ability of the animal to withstand respiratory stress. A suspension of small unilamellar v... | 02/19/2002 |
| 6342515 | Remedy for neurodegenerative diseases The present invention provides a medicament for neurodegenerative diseases comprising zonisamide or an alkali metal salt thereof as an active ingredient. The present medicament can be used in the prevention and treatment of neurodegenerative diseases such... | 01/29/2002 |
| 6300329 | Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas The present invention is directed to the use of certain pyrido[1,2-a]-pyrazine derivatives, also described as bis-azabicyclic compounds and defined by the formula (I) herein, in the treatment of Parkinson's disease, attention deficit hyperactivity disorde... | 10/09/2001 |
| 6277886 | Pharmaceutical compositions comprising S-(-)-N-propargyl-1-aminoindan Pharmaceutical compositions for the treatment of a neurological disorder of neurotrauma or for improving memory in a patient comprising a therapeutically effective amount of S-(-)-N-proparygl-1-aminoindan or a pharmaceutically acceptable salt thereof as a... | 08/21/2001 |
| 6221913 | Dialkyl ureas as calcitonin mimetics Dialkyl urea compounds are described which act as calcitonin mimetics. These compounds are useful in the treatment of diseases which are associated with bone resorption. The calcitonin mimetics of the present invention are also useful in assays for the de... | 04/24/2001 |
| 6187756 | Composition and methods for treatment of neurological disorders and neurodegenerative diseases It has been discovered that the stimulation of ଲ-adrenergic receptors, which activate cAMP formation, give rise to increased APP and GFAP synthesis in astrocytes. Hence, the in vitro or in vivo exposure of neuronal cells to certain compositions comp... | 02/13/2001 |
| 6184255 | Pharmaceutical composition comprising coenzyme Q10 The present invention has for its object to provide a medicinal composition comprising coenzyme Q10 as an active ingredient, which composition features an enhanced absorption after oral administration. The present invention is directed to a med... | 02/06/2001 |
| 6180678 | Use of adrafinil to treat behavioral problems in aged canines A method of treating age related behavorial problems in dogs is disclosed. The method involves administering adrafinil or a metabolite thereof to an animal in need of such treatment.... | 01/30/2001 |
| 6077852 | Treatment of central nervous system disorders with selective estrogen receptor modulators The present invention provides a method of treating depression, mood swings, or Alzheimer's disease in a patient in need of such treatment by administering a selective estrogen receptor modulating compound of the formula ##STR1## in which R... | 06/20/2000 |
| 6063792 | Methods and compositions for treating urinary incontinence using enantiomerically enriched (S)-trihexyphenidyl Disclosed are methods for treating urinary incontinence using enantiomerically enriched (S)-trihexyphenidyl.... | 05/16/2000 |
| 6063797 | γ-RAR antagonist ligand or -RAR agonist ligand as an apoptosis inhibitor The use of a combination of an alpha RAR receptor-specific agonist ligand and a gamma RAR receptor-specific antagonist ligand to reduce the rate of apoptosis is disclosed.... | 05/16/2000 |
| 6056978 | Use of hyperimmune milk to prevent suppression of T-lymphocyte production The invention relates to the use of hyperimmune milk derived from milk producing animals hyperimmunized with bacterial antigens including intestinal bacteria. The present hyperimmune milk effectively prevents the decline of immunological functions observe... | 05/02/2000 |
| 5766640 | Simutaneous treatment of osteoporosis and hypertension A method for simultaneously treating osteoporosis and hypertension in the same individual by the administration of pharmaceutically acceptable alkalinizing potassium salts, such as potassium bicarbonate, preferably in the form of a dietary supplement.... | 06/16/1998 |
| 5736144 | Method of producing a medicinal tea for treating infertility in males and for treating prostatitis A medicinal substance for increasing fertility in mammalian males and for use as an anti-microbial or anti-inflammatory agent by mammals produced by boiling radish leaves, radish stems or portions thereof in water for a period of time sufficient to produc... | 04/07/1998 |
| 5668117 | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments Therapeutic compositions comprising an effective amount of at least one carbonyl trapping agent alone or in combination with a therapeutically effective of a co-agent or medicament are disclosed. The compositions are used to treat a mammal suffering from ... | 09/16/1997 |
| 5550106 | Low buffer nutritional composition A low buffer nutritional composition which is useful to reduce the incidence of colonization of pathogenic bacteria.... | 08/27/1996 |
| 5533836 | Compositions and methods for stimulating the growth of osteoblasts Methods and compositions for stimulating the growth of osteoblasts are disclosed. A composition comprising platelet derived growth factor and vitamin D is applied to osteoblasts in an amount sufficient to stimulate their growth. The methods may be used to... | 07/09/1996 |
| 5514661 | Immunological activity of rhamnolipids Methods for treating various autoimmune diseases and for providing immunorestoration, by administering, to a subject in need thereof, an effective amount of a composition having, as active ingredient, one or more rhamnolipids of formula (I) ##STR1## ... | 05/07/1996 |
| 5466675 | Immunological activity of rhamnolipids Methods for treating various autoimmune diseases and for providing immunorestoration, by administering, to a subject in need thereof, an effective amount of a composition having, as active ingredient, one or more rhamnolipids of formula (I) ##STR1## ... | 11/14/1995 |
| 5254593 | Compositions containing biguanides and derivatives thereof as inhibitors of nonenzymatic cross-linking The present invention relates to compositions and methods for inhibiting nonenzymatic cross-linking (protein aging). Accordingly, a composition is disclosed which comprises an agent capable of inhibiting the formation of advanced glycosylation endproducts... | 10/19/1993 |
| 5221668 | Nutritional product for trauma and surgery patients A liquid nutritional product for trauma and surgery patients has a caloric density of about 1.2 to 1.5 Kcal/mL and a calorie to nitrogen ratio of about 112:1 to 145:1. A portion of the protein system comprises partially digested protein, and supplemental ... | 06/22/1993 |
| 5190923 | Peptide compounds containing a cyclic amide structure The invention relates to compounds of formula (I): ##STR1## in which: A represents, with the carbon and nitrogen atoms to which it is linked, cyclic amide as defined in the description, B represents, with the nitrogen and carbon atoms to which it is linke... | 03/02/1993 |
| 5089472 | Use of growth hormone releasing factor for improving mental function Administration of a Growth Hormone Releasing factor (GRF) at effective dosage levels improves the mental function of attention or short term memory in a subject in need of the treatment. The method of treating comprises the administration to the subject o... | 02/18/1992 |
| 5026701 | Morpholine compounds, compositions and use New morpholine compounds of the formula: ##STR1## in which: X, bonded to the aromatic nucleus, represents halogen or trifluoromethyl and R' represents hydrogen, (C1 -C5)alkyl optionally including a double bond, or aralkyl; in ra... | 06/25/1991 |
| 4908206 | Extracts of embryonic organs, process for their preparation and pharmaceutical preparation containing them From organs of embryonic mammalia a new extract of active ingredients is recovered which extract can be used for controlling a reduced blood flow through periperhic organs and through the brain and which extract can be also used for controlling acne vulga... | 03/13/1990 |
